Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
China flag China · Delayed Price · Currency is CNY
7.11
-0.07 (-0.97%)
Apr 29, 2026, 9:25 AM CST

SHE:002550 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
8,8869,8237,7497,5258,0126,181
Market Cap Growth
22.16%26.77%2.97%-6.07%29.61%13.64%
Enterprise Value
7,6058,7827,0717,0547,5405,582
Last Close Price
7.117.866.095.665.904.45
PE Ratio
27.4724.6321.7641.3824.7734.14
Forward PE
-20.0020.0020.0020.0020.00
PS Ratio
6.016.255.084.153.483.30
PB Ratio
3.123.553.083.043.292.92
P/TBV Ratio
3.253.713.233.233.433.08
P/FCF Ratio
33.9844.7018.2717.38-468.80
P/OCF Ratio
20.7627.1815.0614.11-59.69
EV/Sales Ratio
5.145.594.633.893.272.98
EV/EBITDA Ratio
20.0722.0520.3930.4926.2425.17
EV/EBIT Ratio
24.5026.4125.0643.5033.8836.63
EV/FCF Ratio
29.0839.9616.6816.29-423.36
Debt / Equity Ratio
0.000.000.010.020.040.04
Debt / EBITDA Ratio
0.010.010.060.240.360.42
Debt / FCF Ratio
0.010.010.050.13-7.10
Net Debt / Equity Ratio
-0.45-0.39-0.35-0.27-0.15-0.28
Net Debt / EBITDA Ratio
-3.40-2.72-2.55-2.84-1.30-2.67
Net Debt / FCF Ratio
-4.89-4.92-2.09-1.522.62-44.93
Asset Turnover
0.480.530.550.650.870.76
Inventory Turnover
1.531.641.351.843.032.92
Quick Ratio
5.566.225.394.894.003.83
Current Ratio
7.308.477.587.906.075.30
Return on Equity (ROE)
10.86%14.13%13.35%7.28%14.06%8.91%
Return on Assets (ROA)
6.28%7.02%6.30%3.64%5.24%3.84%
Return on Invested Capital (ROIC)
15.63%16.63%13.77%7.34%11.02%9.41%
Return on Capital Employed (ROCE)
10.50%11.60%10.80%6.30%8.80%6.90%
Earnings Yield
3.63%4.06%4.59%2.42%4.04%2.93%
FCF Yield
2.94%2.24%5.47%5.75%-1.78%0.21%
Dividend Yield
1.67%-1.97%2.12%2.04%2.70%
Payout Ratio
46.38%37.72%42.56%87.31%47.98%83.67%
Buyback Yield / Dilution
1.72%1.99%2.11%-0.41%-7.16%-0.58%
Total Shareholder Return
3.39%1.99%4.08%1.71%-5.13%2.11%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.